Don Cooper Ph.D.

Predictive Models for Settlement Outcomes and Treatment Pathways

• Developed machine learning models to forecast settlement scenarios and recommend optimal legal strategies.
• Created a scoring system using gradient boosting algorithms to evaluate the strength of settlement offers.
• Integrated the model into the firm's case management system, enhancing decision-making processes.
• Conducted training sessions for attorneys on interpreting and utilizing model outputs.
• Implemented natural language processing techniques to automate the summarization of medical records.

Clinical Genome Analysis

• Led Clinical trial using genome sequencing data to support legal cases with genetic evidence.
• Provided personalized genetic counseling to clients, explaining implications for their cases and health.

Marketing and Outreach

• Conceived and produced a high-impact TV commercial highlighting the firm's data science capabilities.

Thought Leadership

• Blog and podcast with over ~100,000 views, covering topics at the intersection of data science, medicine, and law.
  

• Oversee Clinical research in neurological conditions such as traumatic brain injury and Alzheimer’s disease.
• Developed novel nanocapsules for crossing blood-brain barrier, patented in United States.
• Managed collaborations with regulatory agencies such as FDA to secure approvals for investigational diagnostics and compounds.
• Published and presented findings at national and international neuroscience conferences.

• Established Mobile Assay LLC, adiagnostics company utilizing mobile and computer vision technology for global health applications.
• Secured $1M in funding from the Bill and Melinda Gates Foundation for smartphone diagnostics deployed in developing countries, diagnosing diseases like malaria and mycotoxins.
• Developed lab-on-mobile device platforms used in 18 countries for pathogen detection and public health surveillance to screen over 1 million meals for toxins in Africa and help eliminate infectious diseases in Haiti.